The fundamental questions to be dealt with in studies of the cancer process can be broadly divided into two general categories. One involves the events which lead to the origin of the cancer cell, encompassing those intimate intraeellular alterations induced by virus, chemical, or physical eareinogen which lead to the formation of cells with neoplastic potential. The other process involves the possible host reaction to the existent tumor or to the agents responsible for its origin. It is with one aspect of the latter process that this paper will be chiefly concerned, specifically with the phenomena usually designated as "Host Defenses." Reactions on the part of the host, such as vaseularization, which are favorable to the success of the tumor will not be discussed. The presence of a host defense against cancer implies that an organism has the capacity to react with or inactivate oneogenie factors or that, following formation of the neoplastic cell, the host possesses mechanisms to limit the growth of such cells or to destroy them altogether. In bacterial or viral infections where host factors clearly influence the disease state produeed, the immunological, phagocytic, and inflammatory reactions are of unquestionable importance. Similar factors if operative in the primary tumor-bearing host would lead one to postulate either that tumors possess unique antigens capable of elieiting an immune response of varying effectiveness or that the distortion of normal tissue continuity as a consequence of tumor mass or the production by the tumor of substances with irritative properties would induce an inflammatory reaction limiting tumor invasion. The question of specific tumor antigens has long concerned oneologists and immunologists (.30, 37, 39, 8~, 83) . It is obvious that evidence bearing on this problem is relevant only in the ease of primary tumors or in early isologous transplants of such tumors in which the contribution of isoantigens is excluded. Several approaches have been used to detect cancer antigens, only a few of which will be mentioned.
Following immunization of guinea pigs with heterologous tumor tissue and desensitization either in vivo (8~, 83) or in vitro (19, 50-5~) with normal tissue or serum, a further anaphylactic reaction could be elicited by tumor extracts or sera from patients with cancer. Antisera prepared in foreign species against mouse tumor tissue were studied by agar gel diffusion technics and found to contain an antigen specific for the tumor (83). Bjiirklund et al. (14, 15) reported that antisera prepared in horses with pooled human tumor tissue were able to lyse neoplastic cells in vitro; the lyric activity of these sera could be absorbed with neoplastic but not with normal tissue. The evidence from studies which imply the presence of a specific antigen or of antigenic components common to various tumors of the same species must be interpreted with caution. What appears to be a unique tumor antigen may merely reflect a quantitative antigenic difference between tumor and normal tissues or factors extraneous and unrelated to the tumor cells, such as bacterial or viral agents.
A more desirable approach would be to demonstrate inhibition of tumor growth as a consequence of specific immunization and to relate tumor inhibition with a demonstrable immune response of the host. Studies to demonstrate such antitumor immunity in most experimental tumor systems have been largely unsuccessful (~4, ~5, 34, 37). Positive results, however, have been reported with some rodent tumors (1, 33, 66) . Hirseh et al. (40) claimed to have prolonged survival time of mice bearing isologous transplants of spontaneous mammary tumors by repeated prior exposure to cycles of tumor growth and removal. The presence of a unique antigenic component (x-antigen) in murine leukemia has been reported by Gorer and Amos (3~), who used antisera prepared in homologous strains and absorbed in vivo. With irradiated cells (67) or irradiated cells in Freund's adjuvant, 1 immunization with isologous lymphomas has not as yet been accomplished. Cross-reactivity among leukemias within the same inbred strain has been absent or weak (31) . Foley (~6) and Prehn and Main (65) have demonstrated that prior growth of methylcholanthrene-induced tumors in various inbred strains of mice, followed by tumor removal, either surgically or by ligation, rendered the mice resistant to further transplants of the same tumor. R6v6sz (67) has produced a similar state of refractoriness to transplants of methylcholanthreneinduced tumor cells by prior immunization of the animals with irradiated cells derived from the original tumor. Finally, Klein et al. (47) have demonstrated a resistance of the primary host to its own methylcholanthrene-induced sarcoma by repeatedly immunizing with irradiated autologous tumor cells and challenging with cells kept in isologous passage from the original tumor.
Indirect evidence based on morphological changes in draining lymph nodes and spleen, and on the presence of inflammatory cells at the tumor site during growth of primary tumors of mice, rats, and humans, can be interpreted as indicating a host response. Parsons (6~t, 63) and Baruah (3) have noted increased numbers of plasma cells in the lymph nodes and spleens of animals bearing carcinogen-induced tumors. Both sinus histiocytosis in the lymph node draining the tumor site (16, 80) and plasma cell proliferation in draining lymph node and surrounding the tumor (6) have been observed and correlated with a more favorable prognosis. Morphological evidence cannot, however, be interpreted as necessarily indicating a specific immune response, but may have been elicited by products of tumor necrosis or a secondary bacterial or viral infection of the tumor or host.
To understand further the role of the host in the control of tumor growth, we have attempted to alter the development of experimental tumors by conditions which increase natural resistance to experimental infections. Prior treatment with certain agents including endotoxin, zymosan, and infection with Bacillus Calmette-Gu~rin (B.C.G.) has been found to alter favorably the response of 1 Dr. E. A. Boyse, personal communication.
the host to bacterial (~3, 41, 69) or viral challenge (~8, 58, 61, 79) . These agents are capable of enhancing the capacity of the host to form antibody (1s 35) and elic~ting alterations in the macrophage elements of the reticuloendothelial system (RES), including heightened phagocytic activity (5, 7, 9) , increased bactericidal activity of individual macrophages (46) , and greater acid phosphatase activity of the macrophage (75, 76) . Previous reports from this and other laboratories have demonstrated that certain transplanted tumors, as well as a virus leukemia, induce a state of RES hyperactivity as measured by the rate of clearance of colloidal carbon from the blood (10, 18, 59 , 7~) and hyperplasia of phagocytic cells (75, 76) . Furthermore, prior treatment with zymosan (17) and B.C.G. (11, 36, 56) has been found to limit the growth of certain transplanted tumors.
The present study deals further with the relationship of the RES, defined in its broadest sense, to tumor development and growth. The genetic control of phagocytic activity and immune response has been investigated in various inbred strains of mice both under basal conditions and following stimuli which provoke proliferation of RE cells. The response of the RES to tumor growth and virus challenge has been investigated. Attempts to alter tumorigenesis, growth of isologous tumors, and viral infection by agents known to influence the RES will also be reported.
RETICULOENDOTHELIAL FUNCTION IN VARIOUS INBRED STRAINS OF MICE
The use of inbred strains of mice has been essential to experimentation in cancer research. Extensive studies have been performed on a variety of mouse strains to determine biological characteristics which might accurately correlate with the spontaneous or induced tumor incidence in these strains. It has been suggested that reticuloendothelial function, as defined by dye storage and capacity to form antibody, might be deficient in certain high-tumor strains (~1, 70, 71). Davidsohn and Stern have reported that, of eleven strains studied, the five with low tumor incidence demonstrated a more vigorous immune response to heterologous red blood cells than did five of six hightumor strains. Ipsen (44, 45), investigating the immune response to tetanus toxoid in various strains of mice, has reported that BALB/c and C57BL/6 were better antibody-producers than C3H or DBA/~, and, furthermore, random-bred Swiss mice appeared to be superior to most inbred strains in this respect.
With the availability of more accurate technics
Research. (57) .
Assessment of phagocytic activity has been performed by following the rates of clearance of a standard dose of colloidal carbon (16 rag/100 gm body weight) from the peripheral blood according to the technics described by Biozzi et al. (8) . The stabilized preparation of colloidal carbon of homogeneous particle size (about ~50 A) was injected intravenously. Repeated samples of blood were withdrawn from the retroorbital venous plexus, and the carbon concentration in each sample was determined spectrophotometrically. When the logarithms of these values arc plotted against time, they are found to fall along a straight line. The slope of this line, K, is a measurement of phagocytic activity of the RES for the dose of carbon injected. Since approximately 90 per cent of the injected colloid is removed from the circulating blood by the phagocytic cells lining the sinusoids of the liver and the spleen, these organs are removed and their weights correlated with clearance rates.
Chart 1 represents a comparison of the rates of clearance of carbon in Swiss Ha/ICR and A strain mice under both basal conditions and 19 days following infection with 1 nag. (wet weight) Bacillus Calmette-Gugrin (B.C.G.). 2 The response of the RES in various inbred strains to a standardized infection with B.C.G. has been investigated, since this infection causes a sustained hyperactivity of the RES as evidenced by hyperplasia of macrophage elements in the liver and spleen assoeiated with heightened phagocytic activity (7) .
Modifications in phagocytic activity and weights of liver and spleen following B.C.G. infection in normal female Swiss Ha/ICR mice are presented in Chart 3. As a rule, no mortality is observed during the eourse of this infection, and, except for occasional transient weight loss, the dose of B.C.G. used is well tolerated by most strains of mice. The peak of phagocytic activity occurs ~-3 weeks following initiation of infection and then progressively falls. Marked hepatosplenomegaly accompanies the infection, and the weights of these organs remain increased for at least 3-4 months. In our studies we have chosen 18-31 days following infection with B.C.G. as a standard time to compare the response of the different mouse strains.
The following strains of mice were investigated in our various studies: DBA/3, CgH/Bi, JK, BALB/e, C57BL/4 and A. These mice were ob- nesota. In addition, the I, C3H/An, BALB/c and C57BL/C1 (Columbia subline) are maintained by brother-sister mating to an inbred nucleus in our laboratories; two crosses, (Ic? X C3H/An 9)FI and (C3II/Anc? X BALBC/c 9)F1, are derived from these inbred strains. AKR Table 1 show that DBA/~ and CSH produce lower titers of antibody to BruceUa than do C57BL/4 and Swiss H a / I C R mice. Although the differences are not marked, the lower immune response seen in DBA/~ and C3II correlates with their relatively smaller increase in spleen size after B.C.G. infection, as seen in Chart 3.
BACILLUS CALMETTE-GUERIN (B.C.G.) INFECTION
From these studies and the reports of others (~1, 44, 45, 70, 71), it is apparent that there are genetic factors which determine the functional characteristics of the RES and its capacity to respond to infectious or antigenic challenge. As might be expected, random-bred Swiss niice respond more vigorously to the challenges used in these studies than do most inbred strains. Whereas variability in response is less marked within individual inbred strains as compared with Swiss H a / I C R mice, differences among various inbred strains in tcrlns of spleen response to B.C. DBA/2 and C3II strains, a fact confirming the observations of Davidsohn and Stern (~1) and Ipsen (44, 45) with other systems. Since these two strains of mice are known for high spontaneous tumor incidence, it would be tempting to correlate tumor susceptibility to deficient rcticuloendothelial function. However, since tumor development is known to be dependent on a number of complex factors, including the endocrine status of the host and the presence or absence of the mammary tumor agent, such a direct correlation appears as yet unwarranted.
I{ESPONSE OF TIIE R E T I C U L O E N D O T H E L I A L SYSTEM TO T U M O R GROWTH AND C E R T A I N V I R U S INFECTIONS
The observed increase in phagocytic activity of the RES, measured by carbon clearance, (luring the course of various infectious processes suggested that application of these technics to the study of experimental tumors might reveal similar changes. This approach would allow experimental confirInation of the long-postulated relationship between tumor development and growth of the RES (Stern 
I
Mice given injections I.P. of 7 X l0 T heat-killed bacteria every 5 days X3. Bled 7 days after last injection. Each determination represents pooled sera from one to three mice.
and Willheinl [73] ). Biozzi et al. (lO) have observed that growth of a transplanted rat tumor (Guerin carcinoma) is associated with increased phagocytic activity of the RES. Similarly, hyperactivity of the RES has been reported during growth of a number of other transplantable rodent tumors (59, 7~). In contrast, little or no modification in phagocytic activity in mice bearing isologous transplanted tumors or spontaneous tumors was found (13, 59). These findings were interpreted as evidence of participation by the RES in the homograft reaction of tile host to specific isoantigens of the tumors.
Further studies have been made to explore tile mechanism of activation of the RES by transplanted tumors and of factors other than the homograft reaction which might be involved in these phenomena. It has been found that a variety of transplantable tumors or tissues from hosts bearing such tumors contain a transmissible agent(s) which has the capacity to elicit a similar effect on the RES as the growth of the intact tumor cells (60) .
As an example of the changes in phagocytic function of the RES occurring during the course of a transplanted tumor growth, the result of an 
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Vol. gl, October 1961 experiment with Sarcoma 180 (S-180) in Swiss Ha/ICR mice is presented in Chart 4. As can be seen, alterations in phagocytic activity, as measured by carbon clearance (16 mg/100 gm body weight), occur surprisingly early, at a time when the tumor is barely palpable. Another early feature associated with tumor growth is the development of splenomegaly. Both the spleen weight and phagocytic activity return to normal levels prior to death of the animal.
A finding in the course of other experiments that animals bearing S-180 demonstrated a greater resistance to Mengo virus challenge, a fact which could possibly be interpreted as interference by another viral agent, led us to suspect the presence of a transmissible agent in the tumor and tissue of S-180-bearing mice. It was found that homogenates of various tissues of tumor-bearing hosts, when injected into normal Swiss IIa/ICR mice, provoke alterations in the RES and in spleen weights similar to growth of S-180 itself.
To isolate the agent, various tissues including liver, spleen, kidney, and tumor from mice bearing large bilateral passage tumors of S-180 were removed and prepared as a 10 per cent homogenate in ice-cold distilled water. The homogenate was partially clarified by centrifugation at 3000 r.p.m. for ~0 minutes in the cold; 0.~ cc. of the supernatant was injected intraperitoneally into adult female Swiss Ha/ICR mice. The agent has now undergone 25 successive passages at weekly intervals without change in virulence. Chart 5 represents a detailed study of the reaction of the RES to infection with this agent in its sixth through tenth passage. Each point represents an average of data obtained from at least five adult female Swiss IIa/ICR mice. Similar results have been observed with material derived directly from the tumorbearing host.
The general modifications seen in Chart 5 are similar to those seen in Chart 4 except for differences which can be accounted for by tumor growth, including cachexia and death. Apart from the changes described, infected animals continue to gain weight and appear healthy. As early as ~4 hours following inoculation of the agent, the acid (Figs. 1-3) . By 4 days, however, the number of Kupffer cells in the liver is markedly increased as demonstrated both by acid phosphatase and clearance of carbon. At this time, both liver and, in particular, spleen weights are increased, and a leukocytosis of 15-e0,000 WBC/cu mm without change in the differential is apparent during the first 3 weeks following infection. From the 3 Another technic which can be used to investigate macrophage elements of the RES is the Gomori technic for histochemical demonstration of acid phosphatase activity (~9). It has been shown that the maerophage possesses a particularly high concentration of acid phosphatase (~9, 55), and in previous studies (75, 76 ) the number of acid phosphatase-eontaining phagocytic cells in the liver as well as their acid phosphatase content correlated well with the functional state of the RES as measured by carbon clearance. 7th day to the 4th week, the heightened phagocytic activity of the RES falls to normal or slightly above normal activity. The spleen, which increases to approximately 3-8 times its normal weight during the first week of infection, does not appear to return to normal weight for many months. Related to the persistence of the splenomegaly, the S-180 agent can be recovered from the tissues of infected animals as long as 4 months following infection. In Table g some characteristics of the agent or agents isolated from tumor or tissues of S-180-bearing animals are presented. With the use of identical technics for isolation and demonstration of the S-]80 factor, agents with similar characteristics have been recovered from a variety of other transplanted tumors (Table 3 ). In contrast, the tumor or tissues from animals bearing spontaneous or carcinogen-induced tumors, or early isologous transplants of these tumors, have a previously infected host and, in subsequent passage, provoke marked enhancement of RES activity. The growth and behavior of such "infeeted" tumors, however, do not change. Findings such as these suggest that a re-evaluation of the significance of increased phagocytic activity as an indication of participation by the RES in the homograft reaction is necessary. To determine the contribution of the isoantigens of the homograft in these phenomena, tumor systems which possess no transmissible agent demonstrablc by technics used to isolate the S-180 agent have to be employed. An experiment was performed with a tumor induced by methylcholanthrene in female BALB/c mice (Mcth. A). This tumor in its eighth or ninth transplant generation was implanted as bilateral passage pieces into isologous BALB//c and two homologous strains, CgII/An and Swiss IIa/ICR. In contrast to longtransplanted tumors which have lost strain specificity, this tumor will grow only transiently in homologous hosts. Animals in this experiment were studied at 6-7 days following tumor inoculation, since the tumor reaches maxinmm size at this time in homologous hosts, and such an interval is sufficient for the growth of S-180 to cause a high (Table 4) show a small but significant increase in rates of carbon clearance as well as an increase in weights of liver and spleen in both the isologous and homologous host. Observations concerning this particular carcinogen-induced tumor (Meth. A female BALB/c) to be presented in the last section of this paper demonstrate the marked antigenicity of this tumor in isologous hosts. This may account for the small but definite effect oil the RES of isologous tumor growth observed in these experiments. In no way, however, were these Research. Since these agents have been found in tumors which have undergone prolonged passage through innumerable hosts, the possibility of infection with virus unrelated to the tumor is apparent. Transmissible agents have been found in a number of elevation during the early phase of the leukemia.
If the agents described in the present study bear no relationship to tumorigenesis, these findings would emphasize further the need for caution in interpreting data concerning morphological, biochemical, and immunological alterations in the tumor or hosts growing such tumors.
THE I~,ETICULOENDOTttELIAL SYSTEM AND VIRUS INFECTION
Since it is now well established that a variety of tumors have a definite viral etiology, basic information on host factors which might influence virus diseases becomes relevant to a discussion of the cancer problem. In addition, certain virus infections, including the Friend virus leukemia or that infection induced by the agent derived from S-180, (68) . It is most probable that the agent(s) described in our experiments bears no relationship to tumorigenesis. Animals infected with S-180 agent and observed up to 6 months have as yet developed no tumors. Nevertheless, experiments to explore the possible oncogenic activity of the S-180-derived agent injected into newborn mice are in progress. It may be relevant to this problem that a known oncogenic agent causing a reticulum-cell leukemia in mice, the Friend virus (~7), induces similar striking alterations in the phagocytic activity of the RES (Chart 6) (59). Rates of carbon clearance fall approximately 50 per cent ~4 hours after inoculation of this agent and then show progressive have been found to cause marked alterations in RE function.
From other current evidence, there appears to be a definite possibility that phagocytic elements of the RES may be involved in the pathogenesis of Virus diseases. By the use of suitable technics, labeled virus, radioautography, and fluorescent antibodies, a number of viral agents have been shown to localize early in the phagocytic cells of the liver and spleen following intravenous or intraperitoneal injection. The viruses in these studies have included such unrelated infectious agents for animals as ectromelia, Murray Valley encephalitis virus, polio virus (58, 54), vesicular stomatitis, Newcastle Disease virus (18) , and yellow fever (77) . In the case of intravenously or intraperitoneally inoculated ectromelia or yellow fever virus, the first site of virus localization, replication, and damage was found to be the Kupffer elements of the liver (53, 54, 77). In addition, hepatitis virus has been found to have a selective cytopathic ef- Findings such as these suggest that agents which induce proliferation of phagocytic cells, or create within the macrophage an intracellular environment unfavorable for virus replication, might modify the course and lethality of virus infection. Endotoxins, substances known to heighten natural resistance to bacterial challenge as well as to enhmme the phagocytic activity of the RIGS, have been reported to offer a degree of protection in certain virus infections (~28, 79). In addition, certain agents such as trypan red (81) and atabrine (4~, 43), which are phagoeytized by cells of the RES, also alter mortality following virus infection.
To further assess the role of the RES in virus infections, we have studied Mengo virus lethality in mice. Mengo virus produces encephalitis and death in normal Swiss mice within 2.5-5 days following injection by a variety of routes. The consistent and rapid lethality as well as the uniform susceptibility of mice of varying ages have made this virus useful as an experimental model. Infection with B.C.G. with resultant RES hyperplasia has been found to render mice more resistant to Mengo challenge (Table 5 ) (58) . Similar protective activity has been observed with other agents active on the RES (61) . A complete study of these effects and their possible mechanism will be published elsewhere.
The lethality of Mengo virus in mice previously infected with Friend virus (FV), or given inoculations of S-180, or the agent derived from S-180, was also studied. The results of these experiments are presented in Tables 6 and 7 Research.
on October 3, 2017. © 1961 American Association for Cancer cancerres.aacrjournals.org Downloaded from LD~0, is seen as early as 1 day following iiffeetion with FV or the S-180 agent. This resistance to Mengo decreases with time, even though both FV and the S-180 agent can be recovered from the tissues many months after inoculation. Attempts to demonstrate a difference in resistance to Mengo challenge between CStI mice with the mammary tumor agent and foster-nursed C3H without the agent proved unsuccessful.
Since macrophages are a site of virus localization in vivo, and sincc (spccifically in the case of infection with FV and S-180 agent) the RES appears to be rapidly affected, it might be assumed that these viruses also localize and infect RE cells at an early stage. The possibility exists, therefore, that the observed interference in these last experiments occurs at the level of the nmcrophage. It is also of intercst that infection with an oncogenic agent (Friend virus) has been shown to altcr thc outcome of infection with a neurotropic virus. 
ESIS
This section will deal with experiments in which the effect on tumor growth of heightened nonspecific resistance, as measured by bacterial or viral challenge, was investigated. As a means to accomplish this effect, B.C.G. infection was again 'chosen, since this agent causes marked and sustained modification in a variety of factors involved in host resistance. Mice infected with B.C.G. have been found more resistant to bacterial challenge (1~, ~3, 41), to infection with a neurotropic virus (58, 61) , and to ionizing radiation ;6 these mice also exhibit an enhanced immune response to various antigens (1r 35) and possess a hyperactive RES (7, 41, 59) the rate of regression and mortality due to S-180 growth in adult female Swiss Ha,/ICR mice is presented in Table 8 . The greatest degree of protection is obtained with 1 rag. wet weight B.C.G. per mouse and rapidly falls off with lower doses.
In the present studies an attempt has been made to extend these observations to both the development and growth of carcinogen-induced and sponl aneous primary tumors and early isologous transplants of such tumors. On the whole, our results have been in agreement with the findings of others who have attempted to induce immunity to these tumors by various means; B.C.G. infection has had little or no effect on the progression of spontaneous mammary tumors or on isologous transplants of such tumors, with one exception, whereas the growth of early transplants of several carcinogen-induced tumors has been inhibited by previous B.C.G. infection. B.C.G. infection induced at various times following the development of spontaneous mammary adenocarcinomas in a large number of Swiss Webster and C3H/An mice has not altered the growth of these tumors nor prolonged the survival time of the animals. Growth of isologous transplants of such tumors in B.C.G.-infected mice was indistinguishable from that of controls (Chart 7). An exception to these results has been the finding that first-generation transplants of certain (I X C3H/An)F1 spontaneous mammary adenocarcinomas were inhibited when grown in mice infected 7 days previously with B.C.G. (Chart 8).
of our experience with carcinogen-induced tumors in various mouse strains are presented in Table 9 . In a total of 47 tumors definite inhibition of tumor growth or complete regression was observed in 53 per cent of cases studied. Tumors induced by 3-methylcholanthrene appeared to be more often antigenic than those induced by 3,4-9,10-dibenzpyrene. As the latent period for tumor development has been observed to be shorter and the total incidence higher in the case of primary DBP-induced tumors than in those induced by 8-methylcholanthrene, these differences may possibly be related to the variations in tumor antigenicity as noted above. Thus, less antigenic tumor cells would be expected to establish themselves with less difficulty.
The observed antigenicity of carcinogen-induced tumors is in agreement with the findings reported by Foley (~6), Prehn and Main (65), RGvGsz (67), Prehn (64) , and the Kleins et al. (47) . In addition, our data add one more carcinogen, 
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* Survivors/number per group. Survivors were checked until tumor-free.
In the main, however, the negative results observed with most spontaneous mammary tumors are not surprising, since the enhancement of immune mechanisms could not be expected to affect a system where no well defined tumor antigenicity has been observed to date. We therefore initiated studies on carcinogen-induced tumors which have been reported to possess antigens capable of immunizing the isologous (~6, 65, 67) and autologous host (47) .
Tumors were induced in a variety of mouse strains by one subcutaneous injection of 0.05 or 0.1 rag. of either 3-methylcholanthrene (MC) or 3,4-9,10-dibenzpyrene (DBP) dissolved in sesame oil. Trocar pieces of the induced tumors were transplanted to isologous mice of the same sex as the primary tumor donor, allowed to grow for a period until reaching an average tumor diameter of approximately 1-1.5 cm., and then ligated. These animals and controls were challenged at times varying from ~ days to 1 89 months following ligation with a second trocar piece of the same tumor maintained in isologous passage. The results 3,4-9,10-dibenzpyrene, to the two other carcinogens, 3-methylcholanthrene and dibenzanthracene, which have been shown to induce tumors antigenic to their isologous hosts.
The effect of B.C.G. infection on the growth of early isologous transplants of these tumors was next investigated. As might be expected from the reports on the variable antigenicity of carcinogeninduced tumors, the effect of B.C.G. infection on tumor growth was not consistent. The detailed results of these studies are compiled in Table 9 ; 45 per cent of tumors were significantly inhibited; the growth of 10 per cent of the tumors appeared enhanced, whereas 45 per cent of tumors did not seem to be affected when grown in B.C.G.-infected isologous hosts. As an example of the latter situation, the growth of a transplant of a DBP-induced tumor in male BALB//c mice, as shown in Chart 7, was not influenced by previous B.C.G. infection. It was found that previous growth and removal of this tumor in normal mice did not appear to immunize the isologous hosts. As an example of a favorable response, Chart 9 illustrates the be- Table 10 and Chart 10. These two tumors, DBP (I X C3H)F~ female and Meth. A BALB/e female, were found capable of immunizing the isologous host. Although in our experience there has been a correspondence between tumor "antigenicity" and inhibition of growth in B.C.G.-infeeted animals, such a correlation was not complete-i.e., the tumor which was found to immunize most effectively against itself (Meth. A BALB/c female) was not inhibited to any greater degree in B.C.G.-infected mice than other tumors with less capacity to immunize. The inhibitory effect of B.C.G. infection on isologous transplants of DBP-induced tumors was significantly greater in females than in males. The explanation of this difference may relate to the fact that females respond more vigorously than males to bacterial products which induce a proliferative reaction of the RES.
Further experiments of Prehn and Main ( Research. Klein et al. (47) . In view of these findings it would seem pertinent to investigate whether the incidence or growth of carcinogen-induced tumors in the primary host could be affected by B.C.G. infection. Experiments to demonstrate such an effect, however, are difficult to design, since the problem arises as to the optimal time to initiate B.C.G. infection with relationship to the carcinogenic stimulus. Moreover, considering the range of antigenicity observed in the tumors produced by a given carcinogen, one might expect that enhancement of the immune response of the host might only have the effect of suppressing the more antigenic cells with neoplastic potential. Eventually growth of less antigenic or nonantigenic tumor cells could conceivably occur. A net result of this selection process would be a delay in tumor appearance after B.C.G. infection without affecting the ultimate tumor incidence. Experiments to explore these possibilities were carried out in adult Swiss Ha/ICR female mice. 8-Methylcholanthrene dissolved in sesame oil was injected into the right thigh muscle of twenty to ~5 Swiss Ha/ICR mice for each dose of carcinogen studied. A dose response study to determine the critical dose range for tumorigenesis was made and is presented in Chart 11. Two types of experiments with B.C.G. were performed, one in which ani- Research.
on October 3, 2017. © 1961 American Association for Cancer cancerres.aacrjournals.org Downloaded from mals were infected ~ weeks prior to carcinogen injection (Chart 11), and experiments in which B.C.G. infection was initiated at a time corresponding to the emergence of the first tumors (Chart lO~). B.C.G. infection prior to carcinogen injection did not consistently alter the rate of tumor appearance or the final incidence. When infection was initiated 86 days following carcinogen injection, a definite delay in the appearance of tumors was observed, although the final cumulative incidence was eventually similar to that seen in noninfected animals. The B.C.G.-infected animals did show a slight transient weight loss (Chart 1~), which does not seem sufficient to account for the delay in tumor incidence. Similar delays in appearance of leukemia in B.C.G.-infected A K R mice (Chart 13) and in the development of spontaneous m a m m a r y adenocarcinomas in B.C.G.-infected (IXC3H)F~ mice (Chart 14) have also been observed.
The exact mechanism by which B.C.G. infection favorably affects tumor development has not been determined. While it is conceivable that many of the effects of B.C.G. which lead to enhanced host resistance to bacterial or viral challenge may be involved in the alteration of tumor growth, it appears most probable that this effect is the result of a more vigorous or accelerated capacity to reject tissues containing antigens not present in the host. Observations by Dr. H. Balner (personal communication) on the rejection of isologous male skin by female C57BL would lend support to this interpretation. Female mice previously given injections intraeutaneously or intra- * Defined as growth for more than two transplant genera. tions. isologous passage (Table 11) , a possible correlation between these two eharaeteristies beeame apparent. If the failure to establish sueeessful passage of a tumor in isologous hosts ean be interpreted as an indieation of tumor antigenieity, such data might suggest that the tumor eells produced by the action of carcinogens might be more antigenic in certain strains and thus account for the lower tumor incidence in these strains.
The mechanism by which specific antigens are induced during the course of chemical carcino- genesis remains the most important question to be resolved in this particular area of tumor immunology. Although no evidence exists to indicate the processes by which such new antigens might originate, it may be significant that carcinogeninduced tumors, in contrast to viral-induced tumors and tumors of unknown etiology, present chromosomal abnormalities (4, 58, 78). In addilion, the fact that each tumor consists of cells with a variety of ehrolnosomc numbers raises the queslion whether all cells of a given tumor possess the same antigen or antigens, or whether patterns of antigens (lifter from cell to cell in the same tumor. These questions deserve careful investigation. At thc present time, the study of carcinogen-induced tumors appears to us to offer one of the most promising experimental approaches in cancer immunology. 
